Morgan Stanley Upgrades ResMed (RMD) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| RESMED, Inc. (NYSE: RMD) | Delayed: 252.86 -0.2 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.06 | 52 Week High | $70.90 | |||
| Open | $251.83 | 52 Week Low | $50.77 | |||
| Day High | $255.57 | P/E | 113.39 | |||
| Day Low | $248.72 | EPS | $2.23 | |||
| Volume | 1,008,445 | |||||
